Scinovex
article Open AccessTop 1% cited

Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

Heart · 2004 · Vol. 90(3) · pp. 286–292
Simon StewartNiamh MurphyAndrew WalkerAlistair McGuireJohn J.V. McMurray

Abstract

AF is an extremely costly public health problem.

Atrial Fibrillation Management and OutcomesHealth Systems, Economic Evaluations, Quality of LifeHealthcare cost, quality, practicesMedicineEurosPopulationPublic healthMedical prescriptionHealth economicsHealth careEpidemiologyEnvironmental healthTotal cost

MeSH terms

AgedAmbulatory CareAtrial FibrillationCommunity Health ServicesCost-Benefit AnalysisHealth ExpendituresFamily PracticeFemaleUnited KingdomHospitalizationHumansLong-Term CareMaleMiddle AgedNursing Homes

Funding

  • British Heart Foundation
  • National Health and Medical Research Council
Citations
590
FWCI
17.39
field-weighted impact
References
41
Percentile
99%
vs. same field & year
Citations per year
Cited by
The Clinical Profile and Pathophysiology of Atrial Fibrillation
Circulation Research · 2014 · 1,187 citations
Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century
International Journal of Cardiology · 2013 · 633 citations
Warfarin: almost 60 years old and still causing problems
British Journal of Clinical Pharmacology · 2006 · 327 citations
Worldwide Epidemiology of Atrial Fibrillation
Circulation · 2013 · 4,421 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK · Scinovex